Provames

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Provames

Property Description
Active Ingredient Estradiol
Form Oral Tablet
Pharmacological Class Estrogens, Hormone Replacement Therapy (HRT)
Common Use Addressing low estrogen levels (Hypoestrogenism)
Origin Bioidentical (Structurally identical to natural human hormone)

Provames: Defining the Estrogen Replacement Type

Provames is a prescription-only pharmaceutical preparation primarily classified as an Estrogen medication, falling under the larger category of Hormone Replacement Therapy (HRT). Its chemical identity is defined by its function as an Estrogen Receptor Agonist. The general therapeutic purpose of Provames is to address the condition of hypoestrogenism—a deficiency in the body's natural estrogen levels, particularly common in postmenopausal women. Estradiol is a core substance used in replacement therapy to manage symptoms resulting from estrogen deficiency. This use is recognized for its efficacy in restoring hormonal balance, based on established pharmacological data.

Composition and Origin: What is Estradiol?

The active ingredient in Provames is Estradiol (INN), often formulated as Estradiol Hemihydrate. This compound is structurally identical to the 17beta-Estradiol naturally produced by the human ovary, classifying it as a bioidentical estrogen. This structural identity is considered a key feature, as it ensures the molecule interacts with the body's estrogen receptors in the same way the natural hormone does. Provames is provided in the oral tablet dosage form, distinguishing its systemic route of administration from alternative preparations, such as transdermal patches or gels, that contain the same active compound.

High-Level Purpose of Estrogen Replenishment

The high-level goal of Provames is hormonal replenishment. By providing the deficient hormone, it supports the numerous systemic functions that rely on adequate estrogen levels. Its single-ingredient nature ensures the specific therapeutic focus is solely on replacing the estrogen component. This restorative action is aimed at counteracting the systemic effects of estrogen deficiency, thereby providing general therapeutic benefit, for example, in supporting the maintenance of bone mineral density in susceptible patient groups.

Regulatory References

  1. EMA Estradiol Referral
  2. MedlinePlus: Estradiol Drug Information

What side effects are possible with Provames?

Possible Side Effects and Safety Information

Provames (estradiol valerate) is an estrogen-only medication whose safety profile is defined by both common, generally manageable side effects and serious, documented risks associated with systemic estrogen therapy.

Documented Adverse Reactions

The most frequently reported side effects (Very Common, affecting 10% or more of users) include headache, back pain, and arthralgia (joint pain). Other common effects (affecting 1% to 10% of users) involve the nervous system (e.g., migraine, dizziness), gastrointestinal system (e.g., nausea, abdominal pain), and reproductive system (e.g., breast tenderness/pain, irregular uterine bleeding, or spotting).

Frequency Category Examples of Adverse Reactions (Selected)
Very Common (ge 10%) Headache, Back Pain, Arthralgia
Common (1% to < 10%) Migraine, Dizziness, Nausea, Breast Pain, Leg Cramps, Edema (fluid retention)
Uncommon to Rare (< 1%) Anaphylactic reaction, Gallbladder disease, Worsening of Epilepsy

Serious Safety Warnings

Estrogen-only therapy carries important class-specific risks that are explicitly outlined in regulatory documentation:

  • Increased Cancer Risk: Use of unopposed estrogen (without a progestin) in women with an intact uterus significantly increases the risk of endometrial hyperplasia and endometrial cancer. Long-term use may also increase the risk of breast cancer and ovarian cancer.
  • Cardiovascular and Thromboembolic Events: Estrogen use is associated with an increased risk of stroke, deep vein thrombosis (DVT), pulmonary embolism, and myocardial infarction (heart attack). This risk is particularly noted in women aged 50 and older.
  • Probable Dementia: In women aged 65 and older, estrogen-only therapy has been associated with an increased risk of developing probable dementia.

Safety Monitoring and Limitations

Patients should be monitored for signs of thromboembolic events, abnormal vaginal bleeding, and changes in blood pressure. The medication is contraindicated in individuals with a history of known or suspected hormone-dependent cancers, active thromboembolic disease, or undiagnosed abnormal genital bleeding.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information for Provames (Estradiol)

The official regulatory profile for estradiol overdose focuses on documented, acute clinical manifestations and mandated emergency actions. Overdosage is generally associated with a self-limiting pattern of symptoms.

Documented Overdose Manifestations

Clinical manifestations formally described in regulatory documents include common gastrointestinal and systemic effects such as Nausea, Vomiting, Breast tenderness, Abdominal pain, Drowsiness, and Fatigue. In women, an overdose may also result in Withdrawal bleeding [Source: FDA/DailyMed Labeling].

Immediate Actions and Supportive Measures

Immediate medical attention is required if an overdose is suspected. Individuals must seek emergency medical help or contact a Poison Help Line immediately, as stipulated in official guidance. The primary action is the immediate discontinuation of the product.

Treatment consists of initiating appropriate symptomatic and supportive care, as no specific antidote is known for estradiol overdosage. Monitoring of vital signs and laboratory tests may be necessary for management.

Regulators note that serious ill effects have generally not been reported following the acute ingestion of large doses of estrogen-containing oral contraceptives by young children [Source: FDA/DailyMed Labeling].

Therapeutic Uses of Provames

Provames (oral estradiol) is commonly used as a foundational hormone replacement therapy to help with the numerous symptomatic and systemic consequences of estrogen deficiency, a state primarily experienced by women following menopause. Its use is considered relevant in several therapeutic domains where symptomatic support is appropriate.

Relief for Systemic Vasomotor Instability

Oral estradiol is applied in clinical settings that involve systemic imbalance, addressing symptoms related to heightened physiological activity, such as frequent and intense episodes of hot flashes and associated night sweats. Providing this support may assist with managing symptom intensity when manifestations create noticeable physiological strain, contributes to easing the overall symptom load, and supports general well-being during symptomatic phases. The core therapeutic domains it helps manage include vasomotor symptoms, urogenital discomfort, and the management of skeletal risk.

“It is commonly used across conditions presenting with acute or disruptive symptom patterns, and contributes to easing the overall symptom load during symptomatic phases.”

Provames is also relevant in conditions presenting with systemic or localized discomfort, such as urogenital discomfort. It helps address symptoms related to inflammatory or irritative states like vaginal dryness, irritation, and dyspareunia that interfere with daily functioning. Beyond acute symptom management, it is considered relevant for easing the risks associated with significant bone loss for women at increased risk of osteoporotic fracture. This application may assist with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.

Quick Fact: Symptomatic Support for Key Domains

Eligibility and Restrictions for Use

Provames (oral estradiol) is officially authorized for postmenopausal women to manage symptoms associated with estrogen deficiency and for osteoporosis prevention in high-risk patients. Use is also documented for hypoestrogenism due to primary ovarian failure or other specific medical conditions.

The medicine is absolutely contraindicated in several populations, according to governmental regulatory sources. Patients must not use this medicine if they have a history of breast cancer or other estrogen-dependent malignancies, undiagnosed genital bleeding, or known thrombophilic disorders. It is also prohibited in cases of active or prior venous thromboembolism (VTE), arterial thromboembolic disease (e.g., stroke or myocardial infarction), or known liver impairment.

Eligibility is further defined by physiological and age constraints. The medicine is contraindicated during pregnancy and not recommended during breastfeeding. For women with an intact uterus, official labeling requires the mandatory addition of a progestogen to the regimen. Use is not established for children, and women 65 years of age and older are subject to an official regulatory finding regarding an increased risk of probable dementia in this cohort.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for oral estradiol (Provames) is defined by its involvement with hepatic enzymes and specific combination risks documented in regulatory labeling. The primary mechanistic basis for altering estradiol concentration is the Cytochrome P450 3A4 (CYP3A4) enzyme system.

Interactions Affecting Estradiol Concentrations

Co-administration with certain medicinal products and supplements can alter the levels of estradiol in the plasma:

Interacting Substance Type Specific Examples Outcome on Estradiol Concentration
Enzyme Inducers Rifampin, Phenobarbital, St. John's Wort Reduced (may decrease therapeutic effect)
Enzyme Inhibitors Ketoconazole, Ritonavir, Grapefruit juice Increased (may increase the incidence of side effects)

Interactions Affecting Other Drugs

Estradiol can also influence the metabolism of other co-administered substances. Regulatory documents state that estradiol replacement therapy can increase the clearance of the antiepileptic medicine Lamotrigine by inducing the process of glucuronidation. This pharmacokinetic effect results in reduced plasma exposure of Lamotrigine.

Regimen and Population Constraints

A specific constraint is warranted when oral estradiol is co-administered with certain Hepatitis C combination regimens due to the officially documented risk of elevated Alanine Aminotransferase (ALT) liver enzymes. Furthermore, the use of estradiol with thyroid hormone replacement therapy necessitates the monitoring of thyroid function parameters as specified in the official prescribing information.

Mechanism of Action

Provames, which is estradiol valerate, functions as a prodrug that undergoes rapid hydrolysis by endogenous esterases in the systemic circulation to yield the active compound, 17beta-estradiol. The liberated 17beta-estradiol, a steroid hormone, enters target cells via passive diffusion through the cell membrane. Its primary biological targets are the nuclear estrogen receptors (ERs), specifically the ER alpha and ER beta isoforms, where it acts as an agonist.

Upon ligand binding, the 17beta-estradiol-receptor complex dimerizes, translocates to the cell nucleus, and binds to specific DNA sequences known as estrogen response elements (EREs) in the promoter regions of target genes. This binding event modulates gene transcription by recruiting co-activator or co-repressor proteins, leading to a modified rate of messenger RNA synthesis and subsequent protein production (a genomic mechanism).

Additionally, 17beta-estradiol can activate non-genomic pathways by binding to membrane-associated ERs, initiating rapid intracellular signaling cascades such as the Mitogen-Activated Protein Kinase (MAPK) pathway. The system-level consequence of this receptor agonism includes the modulation of gonadotropin secretion from the pituitary gland via negative feedback, which subsequently alters the pulsatile release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).

Dosage and Administration Information

Instruction Map: How to use Provames — Official Administration Guidelines

Provames is an oral medication containing estradiol hemihydrate, and its usage follows prescribing information to ensure a standardized administration protocol.


Administration Scope

Feature Official Instruction
Route of administration Oral only; the tablet must be swallowed whole with liquid.
Dosing schedule Starting dose is typically 1 mg or 2 mg once daily. The standard of use is the lowest effective dose for the shortest duration. The 0.5 mg dose is cited for bone loss prevention.
Timing in relation to meals Can be taken with or without food.
Age-group administration rules Experience in treating women aged 65 years and older is documented as limited.
Special procedural conditions The use of oral estradiol requires the concurrent administration of a progestogen for at least 12 to 14 days per cycle in patients who have an intact uterus.
Missed-dose rules If a dose is forgotten, it must be taken as soon as possible, but only within 12 hours of the scheduled time. If more than 12 hours have passed, the missed dose is to be skipped.

Instruction Classifications (High-Level)

Classification Description
Administration method type Oral Tablet
Frequency pattern Daily (once daily) in either a continuous (uninterrupted) or cyclic regimen.
Use-context constraints Co-administration of a progestogen for women with an intact uterus.

Connection to the Overall Use Protocol

The official usage instructions establish a highly structured protocol, detailing the necessary oral route, the required once-daily frequency, and the official dosing ranges based on the condition being addressed. This protocol explicitly guides patient adherence through rules regarding missed doses and sets the duration constraint by requiring regular re-evaluation of the need for continued treatment.

Recent Clinical Evidence

Research evidence / Overview of studies for Provames

Evidence for Use in Systemic Vasomotor Symptoms

Research has extensively explored the use of oral estradiol in conditions characterized by fluctuating or episodic manifestations, such as hot flashes and night sweats. The primary evidence base comes from short-term Randomized Controlled Trials (RCTs), where postmenopausal women experiencing moderate to severe symptoms were observed over defined time intervals, typically ranging up to three months. Studies monitored how symptoms evolved in the observed populations, and findings describe patterns observed in groups receiving oral estradiol compared to groups receiving placebo. Systematic reviews described patterns related to symptom change based on standardized scales used in research. However, long-term effects are not fully established from dedicated, single-drug RCTs, and there is limited information on the long-term patterns of symptom change.

Evidence for Preventing Postmenopausal Bone Loss

Oral estradiol was studied for its application in conditions marked by functional limitations and systemic imbalance, specifically in research exploring bone density patterns after menopause. The evidence landscape includes a mix of Randomized Controlled Trials (RCTs) and long-term observational cohort studies. The research examined several outcomes reflecting daily functioning, including changes in Bone Mineral Density (BMD) at key skeletal sites over several years. Data show patterns related to the occurrence of bone fractures in women who was observed in over extended periods. A key limitation is that trials primarily focused on measuring BMD change, while fracture incidence data often relies on secondary analyses. The results apply only to the populations studied in the main research.

What Remains Uncertain About Oral Estradiol Research

Evidence quality varies across studies, and several areas remain uncharacterized. The long-term effects are not fully established, particularly for treatments lasting more than five years. Comparative evidence is lacking against all alternative non-hormonal treatments, and subgroup findings for women with certain comorbidities are uncertain. Research provides context but not individual predictions, and findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Estrogen Therapy - StatPearls - NCBI Bookshelf
  2. Menopausal Hormone Therapy (Medscape Reference)
  3. Estrogen Therapy: Overview, Menopausal Transition, Menopause and Hormone Therapy (Medscape Reference)

Frequently Asked Questions (FAQ)

Common questions about Provames (FAQ)


Q: How quickly does Provames start to work for menopause symptoms?

A: Official studies designed to check how well this medication works for symptoms like hot flashes are typically conducted over periods up to three months. While individual experiences vary, a pattern of symptom change is often noted within this timeframe, but individual results may vary.


Q: Does taking Provames increase the risk of blood clots?

A: Yes, official safety warnings state that estrogen therapy is associated with an increased risk of serious cardiovascular and thromboembolic events, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Regulatory warnings emphasize the importance of having personal risk factors assessed by a healthcare provider.


Q: Can I take Provames if I'm already taking a multivitamin?

A: Regulatory documents primarily focus on drug-to-drug interactions with specific prescription medicines and herbal supplements that affect liver enzymes. General multivitamin products are not typically cited as being a concern for significantly altering the medication’s levels in the body.


Q: Does Provames help with hot flashes and night sweats?

A: Yes, the medication is officially authorized for the management of systemic vasomotor symptoms, which is the medical term for symptoms like hot flashes and night sweats. It works by replacing the estrogen lost during menopause.


Q: How long can a person safely stay on Provames?

A: Official regulatory guidance dictates that the lowest effective dose should be used for the shortest duration necessary. Regulatory standards recommend the need for continued treatment be re-evaluated periodically by a healthcare provider.


Q: Why do some people experience breakthrough bleeding while taking Provames?

A: Irregular uterine bleeding, or spotting, is listed as a common side effect of estrogen therapy. In women who have not had a hysterectomy, this can be related to the medication affecting the uterine lining. Skipping a dose may also cause breakthrough bleeding or spotting.


Q: What happens when you stop taking Provames suddenly?

A: Stopping the medication can cause the return of symptoms related to estrogen deficiency, such as hot flashes. Furthermore, unexpectedly stopping the daily regimen may cause breakthrough bleeding or spotting, as the hormone levels are suddenly changed.


Q: What are the alternatives to Provames for HRT?

A: While Provames is an oral estrogen tablet, alternatives include other preparations that contain the same active ingredient but in different dosage forms, such as transdermal patches or gels. Other options include combined HRT products, which contain both estrogen and progestogen, or non-hormonal prescription options.


Q: Is Provames the same as other estrogen pills?

A: Provames contains estradiol valerate, which the body converts into 17β-estradiol, a form structurally identical to the hormone naturally produced by the human ovary (a bioidentical estrogen). Other estrogen pills may contain different chemical forms of estrogen.


Q: Is there a link between Provames and weight gain?

A: Official adverse reaction reports for oral estradiol sometimes list increased or decreased weight as a possible, but not universal, side effect. It is important to report any concerns about weight changes to a healthcare provider.


Q: Can Provames affect my mood or cause anxiety?

A: The list of potential undesirable effects cited in official documents includes reports of anxiety/depressive symptoms and general mood changes. Any significant mood shifts experienced should be discussed with a healthcare provider.


Q: Is it safe to drink alcohol while on Provames?

A: While regulatory documents do not typically specify a direct interaction between alcohol and this medication, health guidance often suggests avoiding excessive alcohol intake when using any systemic medication. Excessive alcohol use can increase the risk of liver issues and may worsen certain side effects.


Q: Are there any age limits for starting or stopping Provames?

A: The medication is not studied for use in children. For women aged 65 years and older, official regulatory information notes an increased risk of probable dementia with estrogen-only therapy. The decision to start treatment is typically made shortly after the onset of menopause symptoms.


Q: How does Provames differ from a combined hormone replacement therapy (HRT)?

A: Provames contains estrogen only (estradiol) as its active ingredient. A combined HRT product contains both an estrogen and a progestogen. The progestogen is mandatory for women who have an intact uterus.


Q: Does Provames affect libido or sexual desire?

A: Official adverse reaction reports for estrogen therapy include both decreased libido and, less commonly, increased libido (sexual desire) among the possible side effects.


Q: Is it normal to feel breast tenderness when starting Provames?

A: Breast pain or breast tenderness is listed as a common adverse reaction, affecting up to 10% of users. This tenderness is often reported when first starting the medication or following a dosage change; this effect may or may not resolve over time.


Q: Can men use Provames for any medical reason?

A: The primary authorized use is for treating postmenopausal women and hypoestrogenism. However, the active ingredient, estradiol, is sometimes used in certain regulatory-approved protocols for gender-affirming hormone therapy (GAHT) and for the treatment of prostate cancer.


Q: Does Provames cause stomach upset or nausea?

A: Nausea and abdominal pain are listed as common gastrointestinal side effects, affecting up to 10% of users. Dyspepsia (indigestion) is also a possible reported effect.


Q: Is Provames available as a patch or gel too?

A: Provames itself is only available as an oral tablet formulation. However, the same active ingredient (estradiol) is manufactured by other companies in different dosage forms, such as transdermal patches and gels, which are also regulated products.


Q: What should I do if my vision changes while taking Provames?

A: Official regulatory documents indicate that the medication should be discontinued pending examination if there is a sudden partial or complete loss of vision, double vision (diplopia), or a new onset of migraine. A healthcare professional should be contacted immediately if such changes occur.


Q: How does Provames affect the uterus lining?

A: Estrogen-only therapy can stimulate the growth of the lining of the uterus (endometrium). For women who have an intact uterus, using estrogen without a progestogen significantly increases the risk of endometrial hyperplasia (thickening) and endometrial cancer.


Q: Is it safe to have surgery while I am on Provames?

A: Due to the increased risk of blood clots (venous thromboembolism, VTE) associated with oral estrogen use, official guidance suggests considering stopping the medication 4-6 weeks before major elective surgery where prolonged immobility is likely. It is important that any planned surgery is discussed with your prescribing healthcare provider.


Q: Can certain herbal supplements interfere with Provames?

A: Yes, one herbal supplement, St. John's Wort, is specifically mentioned in regulatory documentation as an enzyme inducer. This may reduce the level of estrogen in your blood, potentially making the medication less effective.


Q: Are there any foods I should avoid while on Provames?

A: Grapefruit juice is specifically cited in regulatory documents as an enzyme inhibitor. Consuming it may increase the level of estrogen in your blood, potentially increasing the likelihood of side effects.


Q: Does Provames help prevent osteoporosis after menopause?

A: Yes, regulatory documents indicate that the medication is officially authorized for the prevention of osteoporosis in postmenopausal women who are at high risk of future fractures.


Q: Is it normal for my period to change while taking Provames?

A: Changes in vaginal bleeding pattern, including abnormal bleeding or spotting, are listed as common adverse reactions. While these may subside during continued treatment, any unexpected or heavy bleeding should be discussed with a healthcare provider.


Q: Will I need a higher dose of Provames over time?

A: The official regulatory standard is to use the lowest effective dose for the shortest time possible. The dosage is typically reviewed and adjusted based on the continued presence and severity of your symptoms, rather than a guaranteed need for an increase over time.


Q: Is a low dose of Provames effective for menopause symptoms?

A: The starting dose is typically 1 mg or 2 mg once daily, and the standard is to use the lowest effective dose that controls your symptoms. Lower doses are generally cited for bone loss prevention.


Q: Does Provames have a known effect on hair loss?

A: The list of undesirable effects includes reports of both hair loss (alopecia) and hirsutism (excessive hair growth) among the potential skin and tissue reactions.


Q: What is the research on Provames and gallbladder issues?

A: Official adverse reaction reports include gallbladder disease as an uncommon to rare effect. Estrogen therapy, as a class, has been associated with an increased risk of developing gallstones and related issues.


Q: Does Provames affect cholesterol levels?

A: Estrogen therapy may influence lipid profiles. Official warnings note that the use of estrogens has been associated with elevations in triglyceride levels, particularly in patients who already have high levels.


Q: Why is Provames sometimes used in IVF or fertility treatments?

A: Although not the primary authorized use for this brand, the active ingredient, estradiol, is frequently used in fertility treatments. It helps prepare the endometrium (uterine lining) to an optimal thickness and condition for embryo implantation during procedures like IVF.


Q: Do I need to take Provames at the exact same time every day?

A: The tablets must be taken once daily. While it is recommended to take the tablet at the same time every day to maintain consistent levels, the official missed-dose rule allows you to take a dose up to 12 hours after the scheduled time.


Q: What happens if I forget to take a Provames tablet?

A: If you forget a dose, you must take it as soon as you remember, but only if it is within 12 hours of the usual time. If more than 12 hours have passed, you should skip the missed dose and resume your schedule the next day to prevent irregular bleeding.


Q: Why do people say Provames is used for gender transition?

A: The active ingredient, estradiol, is a bioidentical estrogen. It is used as the estrogen component in gender-affirming hormone therapy (GAHT) to promote the development of feminizing secondary sexual characteristics.


Q: Is Provames used to treat acne?

A: Acne is listed as a possible side effect of the medication, and Provames is not officially authorized as a single-ingredient treatment for acne. However, estrogen is an ingredient in some combined hormonal contraceptives that are authorized for treating moderate acne.

How should Provames be stored and disposed of?

Provames (estradiol tablets) must be stored and disposed of according to strict requirements defined in official regulatory documentation to maintain product stability and safety.

Storage Conditions

Provames must be stored at a controlled room temperature, typically 20 C to 25 C (68 F to 77 F), and must not be exposed to temperatures above 25 C or to freezing conditions. The product must be kept in its original container to protect it from light and moisture.

Handling and Child Safety

To prevent accidental exposure, the medication must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Provames must not be discarded in ordinary household waste or by flushing it into the wastewater system. Official instructions require disposal through local community take-back programs or by returning it to a pharmacist for appropriate handling as pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Provames found in:

A-Z Index: